A second study shows that men infected with the strains of HPV associated with cervical cancer have evidence of sperm death and lower rates of fertility.
Clinicians should strongly recommend routine vaccinations for teens and verify that all—especially those in the Vaccines for Children program—are up to date, the authors say.
The chances of pediatric HPV vaccination were twice as high for mothers than for fathers.
Public-facility patients also had 38% lower odds of receiving a clinician recommendation for the vaccine than those at private centers.
Children with a vaccine-hesitant parent varied by vaccine: 56% for COVID, 31% for flu, 30% for HPV, and 12% for other childhood illnesses.
In women offered HPV vaccination at age 12 and/or 13 years, rates of cervical cancer and precancerous lesions were, respectively, 84% and 94% lower.
Compared to last year, cholera cases are down 32%, but deaths are up 14%.
Uptake is even lower in men, Hispanic respondents, and people with less education.
There was no significant association between HPV, metabolic syndrome, and death in men.
The new efforts hinge on broader HPV vaccine access, along with better screening and treatment.
